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Xanthorrhizol, isolated from Curcuma xanthorrhiza, has been shown to induce cell cycle arrest and 
apoptotic cell death by mainly mitochondrial-dependent signaling pathway in several human cancer cells. 
We investigated whether xanthorrhizol could apoptosis in HL-60 human promyelocytic leukemia cells. 
Xanthorrhizol treatment inhibited cell viability and induced apoptotic cell death. The levels of procas-
pase-3, -8 and -9 were reduced and the cleavage of full length PARP was clearly observed in xan-
thorrhizol-treated cells. Xanthorrhizol treatment did not affect Bcl-2 protein level but increased Bax protein 
level, resulting in the diminished Bcl-2/Bax ratio. The levels of cleaved Bid, Fas death receptor and p53, 
not FasL, were also increased by xanthorrhizol treatment. In conclusion, molecular cross talks between 
the intrinsic and extrinsic apoptotic pathway via Bid may play an important role for induction of apoptosis 
in xanthorrhizol-treated HL-60 cells. Therefore, xanthorrhizol has the chemorpeventive and anti-cancer 
potential against human promyelocytic leukemia cells. (Cancer Prev Res 18, 41-47, 2013)
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INTRODUCTION
  Acute promyelocytic leukemia (APL) with its specific mor-
phology and abnormality on chromosomes 15 and 17 is highly 
malignant form of acute myeloid leukemia (AML), and charac-
terized by numerous promyelocytes in the blood and bleeding 
tendencies from a low fibrinogen level and platelet count. It 
requires prompt treatment as a medical emergency and its 
treatment may last one to two years. Thus, commonly used 
drugs for the treatment of APL have been known to cause di-
verse side effects or complications, including bleeding related 
to coagulopathy, differentiation syndrome, hyperleukocytosis, 
myelosuppression, and hepatic or cardiac toxicity.1)
  One of the attractive strategies considered in current cancer 
chemoprevention/chemotherapy is dietary or pharmaceutical 
manipulation to induce apoptotic cell death in preneoplastic or 
malignant cells with chromosomal aberration.2) There is accu-
mulated evidence that phytochemicals in medicinal herbs and 
dietary plants exert cancer chemopreventive or anticancer activ-
ity by inducing apoptosis in cancer cells.3∼7) Curcuma xanthor-
rhiza Roxb. (Zingiberaceae), known as temulawak or Javanese 
tumeric, has been traditionally used in Indonesia for dietary 
and medicinal purposes.8) Xanthorrhizol (Fig. 1A) is a sesqui-
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Fig. 1. The induction of apoptosis in xanthorrhizol-treated HL-60 cells. (A) Chemical structure of xanthorrhizol. (B) HL-60 human 
promyelocytic leukemia cells were cultured in serum-free RPMI 1640 medium with various concentrations of xanthorrhizol for 24 
h. Cell viability was measured by a MTT assay. (C) The extracted DNA was electrophoresed on 1.8% agarose gel with ethidium 
bromide. M: 1 kb DNA ladder size marker. (D) The cells treated with 40 μM xanthorrhizol were stained with Hoechest 33258 
and observed with fluorescence microscopy (×400). (E) The cellular DNA was stained with propidium iodide and the stained 
cells were analyzed with a flow cytometer. Data were the representative of three-independent experiments.
terpenoid isolated from C. xanthorrhiza that has been known 
to possess diverse pharmacological activity, including anti-
bacterial against oral pathogens,9) anti-inflammatory, and anti-
oxidant.10) In addition, xanthorrhizol showed antiproliferative 
and apoptosis-inducing activity in human colon, breast, liver, 
and cervical cancer cells,11∼15) as well as anticarcinogenic and 
antimetastatic activity in mice.16,17) Xanthorrhizol induced 
apoptosis by modulating protein levels of anti-apoptotic Bcl-2, 
tumor suppressor p53, and poly-(ADP-ribose) polymerase (PARP) 
for DNA repair in MCF-7 estrogen-receptor positive breast 
cancer and HepG2 hepatoma cells. Pro-apoptotic Bax protein 
level was not changed by xanthorrhizol treatment in these 
cells.11,12) In contrast, xanthorrhizol upregulated Bax protein 
and did not affect Bcl-2 expression in HeLa cervical cancer 
cells.13) Xanthorrhizol also induced apoptosis through the mi-
tochondrial-mediated pathway, closely related with caspase-3 
and caspase-9 but not caspase-6 or caspase-8, in MDA-MB- 
231 estrogen-receptor negative breast cancer cells.14) In HCT116 
human colon cancer cells, xanthorrhizol arrested cell cycle pro-
gression in the G0/G1 and G2/M and induced apoptosis via 
release of cytochrome c, activation of caspases, cleavage of 
PARP, and upregulation of pro-apoptotic non-steroidal anti-in-
flammatory drug-activated gene-1.15) In addition, xanthorrhizol 
showed potent neuroprotective effects on glutamate-induced 
neurotoxicity and reactive oxygen species (ROS) generation in 
the murine hippocampal HT22 cell line.18)
  Given that xanthorrhizol substantially restricts the pro-
liferative activity of some cancer cell types, the present studies 
were undertaken to determine whether xanthorrhizol could in-
hibit the growth of the human HL-60 promyelocytic leukemia 
cells. We found that xanthorrhizol induced apoptosis in human 
myeloid leukemia cells through both mitochondrial- and death 
receptor-mediated pathways. Xanthorrhizol induces apoptotic 
cell death via differential signaling pathway in different cancer 
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types, thereby it has the high potential to develop as a benefi-
cial agent for cancer prevention and anti-cancer.
MATERIALS AND METHODS
1. Materials
  Xanthorrhizol was provided by Professor Jae-Kwan Hwang, 
a coauthor.19) It was dissolved with dimethyl sulfoxide (DMSO) 
and diluted with cell culture medium for experiments. RPMI- 
1640 medium, phosphate-buffered saline (PBS) and fetal bovine 
serum (FBS) were purchased from Gibco BRL (Grand Island, 
NY). 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT), sodium dodesyl sulfate (SDS), RNase, proteinase 
K, Hoechst 33258, were obtained from Sigma-Aldrich (St. 
Louis, MO, USA). The following primary antibodies were pur-
chased from their respective sources: procaspase-8, procas-
pase-9, cytochrome c, Bax, Bcl-2, Fas and p53 (Santa Cruz 
Biotechnology, Santa Cruz, CA, USA), β-actin (Sigma-Aldrich 
Chemicals), procaspase-3 (Transduction Laboratories, Lexing-
ton, KY, USA), PARP (New England BioLab, Beverly, MA, 
USA), Bid (R&D Systems, Minneapolis, MN, USA), Smac/ 
DIABLO (Upstate Biotechnology, Lake Placid, NY, USA), 
FasL (BD Biosciences, Bedford, UK). Secondary antibodies con-
jugated to horseradish peroxidase were obtained from Santa 
Cruz Biotechnology. All other chemicals and reagents were the 
highest grade commercially available.
2. Cell culture and in vitro cytotoxicity assay
  HL-60 human promyelocytic leukemia cells were maintained 
in RPMI 1640 supplemented with 10% FBS in a humidified 
atmosphere of 5% CO2 at 37oC. Cells (1×104 cells) were seeded 
into each well of a 96-well plate with RPMI 1640 m and cul-
tured overnight. The cells were exposed to serum-free media 
with various concentrations of xanthorrhizol for 24 h. Then, 
a MTT solution (1 mg/ml) was added and the plates were in-
cubated for 4 h at 37oC. The cellular formazan product was 
dissolved with DMSO and the absorbance was measured at 570 
nm using a microplate reader (BIO-RAD, Hercules, CA, USA).
3. DNA fragmentation
  HL-60 cells (5×105 cells/ml) were cultured in serum-free me-
dia with different concentrations of xanthorrhizol for 24 h and 
washed twice with ice-cold PBS. The cells were lysed with 500
μl lysis buffer (1% Triton X-100, 50 mM Tris-HCl, pH 7.5, 
20 mM EDTA) for 1 h on ice. Lysates were centrifuged at 
1,000×g for 10 min and the supernatants were incubated for 
4 h at 55oC with 50 μg/ml RNase A, 120 μg/ml proteinase 
K and 0.5% SDS. DNA was extracted with phenol/chloro-
form/isoamylalcohol (25：24：1) and precipitated with ice- 
cold absolute ethanol. After the precipitates were resuspended 
with 30 μl TE buffer (10 mM Tris-HCl, pH 8.0, 1 mM 
EDTA), each DNA sample was electrophoresed on 1.8% agar-
ose gel with 0.5 μl/ml ethidium bromide, and then visualized 
under UV light.
4. Hoechst 33258 nuclear staining
  HL-60 cells (1×106 cells/ml) at 70∼80% confluence were 
treated with 40 μM xanthorrhizol for 24 h, fixed with 4% 
paraformaldehyde for 30 min at room temperature, and washed 
with PBS. The fixed cells were treated with 50 ng/ml Hoechst 
33258 for 30 min at room temperature and washed with PBS 
again. The cells were mounted and their nuclear morphology 
was examined by fluorescence microscopy.
5. Flow cytometric analysis
  HL-60 cells were treated with 20 or 40 μM xanthorrhizol 
for 24 h. The cells (1×105 cells) in 100 μl of PBS were treated 
with 200 μl of 95% ethanol, incubated at 4oC for 1 h, washed 
with PBS, and resuspended with 250 μl of 1.12% sodium cit-
rate buffer (pH 8.4) with 12.5 μg of RNase. Additional in-
cubation was continued for 30 min at 37oC. The cellular DNA 
was then stained with 250 μl of propidium iodide (50 μg/ml) 
for 30 min at room temperature. The stained cells were de-
tected by a FACScan flow cytometer (BD Biosciences) and the 
cytometric data were analyzed using a commercially available 
software package (Winlist Version 5.0; Verify, Topsham, ME, 
USA). Assessment of apoptosis was determined by monitoring 
the sub-diploid population.
6. Immunoblot analysis
  Total protein was extracted from HL-60 cells (1×106 cells/ 
ml) with lysis buffer containing 150 mM NaCl, 1 mM sodium 
EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium py-
rophosphate, 1 mM β-glycerophosphate, 1 mM sodium ortho-
vanadate, 1 mM phenylmethylsulfonyl fluoride, 1 μg/ml leu-
peptin and 20 mM Tris-HCl, pH 7.5 for 90 min. The lysates 
were centrifuged at 2,000×g for 15 min. To obtain the mi-
tochondrial and cytosolic fractions, HL-60 cells were resus-
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Fig. 2. Activation of caspases and PARP cleavage in xanthorrhizol-treated HL-60 cells. HL-60 cells were treated with 40 μM 
xanthorrhizol at the indicated time points or with various concentrations of xanthorrhizol for 9 h. The levels of target proteins in 
the extracted lysates were detected by immunoblotting with the specific primary antibodies. Data were the representative of 
three-independent experiments.
pended in 3 volumes of lysis buffer containing 20 mM Hepes, 
pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 1 mM sodium EDTA, 
1 mM sodium EGTA, 1 mM dithiothreitol, and 10 mM phe-
nylmethylsulfonyl fluoride, 10 μM leupeptin, 10 μM aproti-
nin, and 250 mM sucrose. After chilling on ice for 3 min, the 
cells were disrupted with a glass homogenizer. The homogenate 
was centrifuged twice at 2,500×g at 4oC to remove unbroken 
cells and nuclei. The mitochondria were then pelleted by cen-
trifugation at 12,000×g for 30 min and suspended with lysis 
buffer. The supernatant was filtered through 0.2 μm and then 
0.1 μm Ultrafree MC filters (Millipore) to collect cytosolic 
proteins. Protein concentration was measured using a BCA as-
say kit (Pierce).
  The protein extracts (30 μg) were subjected to SDS-poly-
acrylamide gel electrophoresis and the blots on the gel were 
electrotransferred onto polyvinylidene difluoride membrane. 
The membranes were blocked with 10% skim milk and 0.1% 
Tween 20 in PBS and then were incubated with the specific 
primary antibodies against target proteins at a 1：1,000 dilu-
tion in PBS for 1 h at room temperature. After washing, the 
membranes were incubated with horseradish peroxidase-con-
jugated anti-mouse, anti-goat or anti-rabbit IgG antibodies at 
a 1：5,000 dilution for 1 h at room temperature. The target 
proteins were detected with an enhanced chemiluminescence 
detection kit (Amersham Life Science, Little Chalfont, UK) ac-
cording to manufacturer’s protocol.
RESULTS AND DISCUSSION
  The search for new chemopreventive and antitumor agents 
that are more effective and less toxic has kindled great interest 
in phytochemicals. In particular, apoptosis-inducing phytoche-
micals have high potential for suppression of carcinogenesis and 
cancer progression because apoptosis is considered as a defense 
strategy against tumorigenesis. Xanthorrhizol, isolated from the 
rhizome of the plant Curcuma xanthorrhiza, has been shown to 
induce cell cycle arrest and apoptotic cell death by mainly mi-
tochondrial-dependent signaling pathway in several human can-
cer cells.11∼15) In this study, we investigated whether xanthor-
rhizol could apoptosis in HL-60 human promyelocytic leukemia 
cells. As a result of a MTT assay, xanthorrhizol treatment for 
24 h inhibited cell viability in a dose-related manner (IC50= 
28.2 μM) (Fig. 1B). Xanthorrhizol treatment at 40 μM re-
sulted in internucleosomal DNA fragmentation (Fig. 1C) and 
the generation of apoptotic bodies (Fig. 1D). The sub-G1 
(sub-1N, M1) fraction was dose-dependently increased in 
HL-60 cells treated with xanthorrhizol for 24 h (Fig. 1E).
  Next, we determined the molecular mechanism by which 
xanthorrhizol induces apoptosis in HL-60 cells. The character-
istic biochemical and morphological changes displayed by apop-
totic cells in response to a variety of stimuli have been recog-
nized to orchestrate by caspases, which are synthesized in cells 
as inactive zymogens procaspases and can be activated by pro-
teolytic cleavage.20,21) Apoptosis proceeds via two distinct cas-
pase cascades designated as intrinsic and extrinsic pathways.22,23) 
Mitochondrial-mediated (intrinsic) pathway via caspase-9 and 
death receptor-activated (extrinsic) pathway via caspase-8 con-
verge at caspase-3 and finally induce cell death via caspase-3- 
mediated cleavage of PARP.24,25) In this study, we found that 
the levels of procaspase-3, -8 and -9 was reduced in a time-de-
pendent and dose-dependent fashion in HL-60 cells exposed to 
xanthorrhizol. The cleavage of full length PARP (116 kDa) to 
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Fig. 3. The levels of cytosolic cytochrome c, Smac, and proapoptotic and antiapoptotic Bcl-2 family. HL-60 cells were treated 
with 40 μM xanthorrhizol at the indicated time points or with various concentrations of xanthorrhizol for 9 h. The cells were extracted 
with lysis buffer and cytosolic and nuclear fractions were obtained the extracted cell lysates as described in materials and methods. 
The levels of target proteins in total lysates or cytosolic and nuclear fractions were detected by immunoblotting with the specific 
primary antibodies. Data were the representative of three-independent experiments.
fragment (85 kDa) was clearly observed when the cells were 
treated with 40 μM xanthorrhizol for 6 h and more than 6h 
(Fig. 2). These results suggest that xanthorrhizol may induce 
apoptosis via both death receptor and mitochondrial pathway.
  We further detected the levels of a Bcl-2 family, cytochrome 
c, and Smac in xanthorrhizol-treated HL-60 cells. The activa-
tion of caspase-9 and caspase-3 relies on the release of cyto-
chrome c from the intermembrane space of mitochondria to cy-
tosol, which occurs in response to several apoptotic stimuli in-
cluding serum deprivation, DNA damage, and activation of cell 
surface death receptors.26) Recently, second mitochondria-der-
ived activator of caspases (Smac), released together with cyto-
chrome c from the mitochondria in response to apoptotic stim-
uli, was found to promote caspase activation by binding and 
neutralizing the inhibitor of apoptosis proteins (IAPs), which 
blocks caspase-9 and caspase-3 activity.27,28) In this study, xan-
thorrhizol treatment increased cytosolic levels of cytochrome c 
and Smac and decreased mitochondrial level of these in a time 
and dose-dependent manner (Fig. 3A). Mitochondrial functions 
during apoptosis are controlled by the Bcl-2 family localized 
at the outer mitochondrial membranes.29) The antiapoptotic 
Bcl-2 interrupt cytochrome c release from mitochondria, where-
as the pro-apoptotic Bax with three multi-domains plays a ma-
jor role in initiating cytochrome c release. Thus, Bcl-2/Bax ratio 
within the cytosol has been eventually accepted to decide 
whether the cell takes into apoptotic pathway.30,31) Bax can be 
caspase-independently activated by cytosolic p53 tumor sup-
pressor protein in intrinsic pathway. The translocated p53 into 
the mitochondria physically interacts with Bcl-2 and Bcl-xL 
and antagonizes their anti-apoptotic stabilization of the outer 
mitochondrial membrane, leading the release of Bax.32) Extrin-
sic pathway can also activate Bax with Bid, which is the 
BH3-only protein that links death receptor to pro-apoptotic 
events at mitochondria and cleaved to truncated Bid (tBid) by 
caspase-8. The translocated tBid to mitochondrial membrane 
triggers mitochondrial outer membrane permeabilization by 
promoting oligomerization of the pro-apoptotic Bcl-2 family 
proteins Bak and/or Bax, resulting in egress of cytochrome c 
and Smac/DIABLO from the mitochondrial intermembrane 
space.33,34) Our data indicated that xanthorrhizol treatment did 
not affect Bcl-2 protein level but increased Bax protein level, 
resulting in the diminished Bcl-2/Bax ratio. The level of cleaved 
Bid was also increased by xanthorrhizol treatment (Fig. 3B). 
In addition, we detected that FasL expression was not changed 
but Fas death receptor and p53 was upregulated in xanthor-
rhizol-treated HL-60 cells (Fig. 4). These results demonstrate 
that xanthorrhizol induced apoptotic death of HL-60 cells by 
releasing mitochondrial cytochrome c and Smac into cytoplasm 
by p53-mediated Bax upregulation, which triggered the proteo-
lytic activation of a series of caspases and subsequent cleavage 
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Fig. 4. The levels of p53, Fas death receptor and FasL in xanthorrhizol-treated HL-60 cells. HL-60 cells were treated with 40 
μM xanthorrhizol at the indicated time points or with various concentrations of xanthorrhizol for 9 h. The levels of target proteins 
in total lysates were detected by immunoblotting with the specific primary antibodies. Data were the representative of three-in-
dependent experiments.
of the DNA repair enzyme PARP leading to internucleosomal 
DNA fragmentation. In addition, xanthorrhizol treatment may 
result in tBid-dependent Bax activation by upregulating Fas 
death receptor and activating caspase-8.
CONCLUSION
  In conclusion, xanthorrhizol treatment induces apoptosis of 
HL-60 cells via both intrinsic and extrinsic apoptotic pathway. 
Molecular cross talks between the two pathways via Bid may 
play an important role for induction of apoptosis in xanthor-
rhizol-treated HL-60 cells. Therefore, xanthorrhizol has the 
chemorpeventive and anti-cancer potential against human pro-
myelocytic leukemia cells. 
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